2019 Q1 Sentiment Accuray Inc (NASDAQ:ARAY)

Accuray Incorporated (NASDAQ:ARAY) Logo

Sentiment for Accuray Inc (NASDAQ:ARAY)

Accuray Inc (NASDAQ:ARAY) institutional sentiment decreased to 1.39 in 2019 Q1. Its down -0.53, from 1.92 in 2018Q4. The ratio worsened, as 68 investment professionals increased or started new stock positions, while 49 reduced and sold their positions in Accuray Inc. The investment professionals in our partner’s database now have: 67.32 million shares, up from 66.74 million shares in 2018Q4. Also, the number of investment professionals holding Accuray Inc in their top 10 stock positions increased from 0 to 2 for an increase of 2. Sold All: 19 Reduced: 30 Increased: 43 New Position: 25.

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company has market cap of $269.35 million. The firm offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. It currently has negative earnings. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally.

The stock decreased 8.66% or $0.29 during the last trading session, reaching $3.06. About 2.23M shares traded or 282.84% up from the average. Accuray Incorporated (NASDAQ:ARAY) has risen 10.40% since August 15, 2018 and is uptrending. It has outperformed by 10.40% the S&P500.

Archon Capital Management Llc holds 4.16% of its portfolio in Accuray Incorporated for 3.20 million shares. Lapides Asset Management Llc owns 1.07 million shares or 1.93% of their US portfolio. Moreover, Adirondack Research & Management Inc. has 1.58% invested in the company for 532,262 shares. The Wisconsin-based Heartland Advisors Inc has invested 1.21% in the stock. Eam Investors Llc, a California-based fund reported 199,266 shares.

More notable recent Accuray Incorporated (NASDAQ:ARAY) news were published by: Nasdaq.com which released: “Here’s Why You Should Sell Accuray (ARAY) Stock Right Now – Nasdaq” on June 05, 2018, also Globenewswire.com with their article: “Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics — New Research Emphasizes Economic Growth – GlobeNewswire” published on February 01, 2019, Seekingalpha.com published: “Accuray inks JV in China – Seeking Alpha” on January 28, 2019. More interesting news about Accuray Incorporated (NASDAQ:ARAY) were released by: Nasdaq.com and their article: “Accuray (ARAY) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release – Nasdaq” published on August 08, 2019 as well as Nasdaq.com‘s news article titled: “After-Hours Earnings Report for August 15, 2019 : NVDA, AMAT, PAGS, ZTO, GLOB, VIAV, CRMT, ARAY, ARCT, VJET – Nasdaq” with publication date: August 15, 2019.

Accuray Incorporated (NASDAQ:ARAY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.